Giri, L., Singh, R., Marey, A., Li, Y., Venkatesh, B. A., Abdulla, J., Zimmerman, S., & Umair, M. (2025). Diagnostic performance of cardiovascular magnetic resonance parametric mapping as per modified Lake Louise Criteria in acute myocarditis: an updated systematic review and meta-analysis. Journal of Cardiovascular Imaging, 33(1). https://doi.org/10.1186/s44348-025-00048-3

Nitsche, C., Dobner, S., Rosenblum, H. R., Patel, K. P., Longhi, S., Yilmaz, A., Merlo, M., Papathanasiou, M., Griffin, J., Oerlemans, M. I. F. J., Gama, F., Hamdan, A., Kelion, A. D., Schuster, A., Glaveckaité, S., Akyol, N., Porcari, A., Schlender, L., Capovilla, T., … Treibel, T. A. (2025). Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis. European Heart Journal. https://doi.org/10.1093/eurheartj/ehaf362

Judge, D. P., Alexander, K. M., Cappelli, F., Fontana, M., Garcia-Pavia, P., Gibbs, S. D. J., Grogan, M., Hanna, M., Masri, A., Maurer, M. S., Obici, L., Soman, P., Cao, X., Lystig, T., Tamby, J.-F., Siddhanti, S., Castaño, A., Katz, L., Fox, J. C., … Gillmore, J. D. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology, 85(10), 1003–1014. https://doi.org/10.1016/j.jacc.2024.11.042

Merello Oyarzún, G., Olivares-Costa, M., Basile, L., Pástor, T. P., Mendoza-Soto, P., Padilla-Santiago, L., Mardones, G. A., Binda, C., & Opazo, J. C. (2025). Evolutionary and Functional Analysis of Monoamine Oxidase F (MAO F): A Novel Member of the MAO Gene Family. Genome Biology and Evolution. https://doi.org/10.1093/gbe/evae280

Akita, K., Kusunose, K., Haga, A., Shimomura, T., Kosaka, Y., Ishiyama, K., Hasegawa, K., Fifer, M. A., Maurer, M. S., & Shimada, Y. J. (2024). Deep learning of echocardiography distinguishes between presence and absence of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy. Echo Research & Practice, 11(1). https://doi.org/10.1186/s44156-024-00059-8

Jiang, N., Xu, W., Abdelhakim, A., Matveyenko, A., Szabolcs, M., Copeland, W. C., Disco, M., Iglesias, A., Lee, T. M., Naini, A., & Ganapathi, M. (2024). Biallelic potential disease-causing missense variants in TAF1A in two siblings with infantile restrictive cardiomyopathy. European Journal of Medical Genetics, 71, 104968. https://doi.org/10.1016/j.ejmg.2024.104968

Coratti, G., Civitello, M., Rohwer, A., Albamonte, E., Montes, J., Glanzman, A. M., Pasternak, A., De Sanctis, R., Young, S. D., Duong, T., Mizzoni, I., Milev, E., Sframeli, M., Morando, S., D’Amico, A., Catteruccia, M., Brolatti, N., Pane, M., Scoto, M., … Mercuri, E. (2024). Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb Module. Neuromuscular Disorders, 104449. https://doi.org/10.1016/j.nmd.2024.08.006

Godown, J., Kim, E. H., Everitt, M. D., Chung, W. K., Lytrivi, I. D., Kirmani, S., Kantor, P. F., Ware, S. M., Ballweg, J. A., Lal, A. K., Bansal, N., Towbin, J., Lipshultz, S. E., & Lee, T. M. (2024). Genetic Testing Resources and Practice Patterns Among Pediatric Cardiomyopathy Programs. Pediatric Cardiology. https://doi.org/10.1007/s00246-024-03498-6

Yasuda, R., Osawa, I., Goto, T., Hasegawa, K., Fifer, M. A., Tower-Rader, A., Reilly, M. P., Maurer, M. S., Zhao, Y., Takayama, H., & Shimada, Y. J. (2024). Mortality After Alcohol Septal Ablation vs. Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy. Circulation Reports, 6(3), 74–79. https://doi.org/10.1253/circrep.cr-23-0101

Hayashi, H., Singh, S. K., Hahn, R. T., Akita, K., Kurlansky, P., Sun, J., Vedula, V., Leb, J. S., Shimada, Y. J., Weiner, S. D., & Takayama, H. (2024). Mitral regurgitation mechanisms related to systolic anterior motion in hypertrophic cardiomyopathy. Journal of Thoracic Disease, 16(1), 26–39. https://doi.org/10.21037/jtd-23-1206

Nguyen, S. N., Chung, M. M., Vinogradsky, A. V., Richmond, M. E., Zuckerman, W. A., Goldstone, A. B., & Bacha, E. A. (2023). Long-term outcomes of surgery for obstructive hypertrophic cardiomyopathy in a pediatric cohort. JTCVS Open, 16, 726–738. https://doi.org/10.1016/j.xjon.2023.09.032

Goldman, J. S., Uhlmann, W. R., Naini, A. B., Klitzman, R. L., & Marder, K. S. (2023). Genetic Testing of HTT Modifiers for Huntington’s Disease: Considerations for Clinical Guidelines. Movement Disorders, 38(12), 2151–2154. Portico. https://doi.org/10.1002/mds.29650

Akita, K., Hasegawa, K., Maurer, M. S., Tower-Rader, A., Fifer, M. A., Topkara, V. K., Reilly, M. P., & Shimada, Y. J. (2023). Prediction of acute heart failure events in patients with hypertrophic cardiomyopathy using RNA-Sequencing of plasma small non-coding RNAs. European Heart Journal, 44(Supplement_2). https://doi.org/10.1093/eurheartj/ehad655.1840

Adrichem, R., Bouwmeester, S., Abdelkarim, O., Vogel, B., Blusztein, D. I., Veulemans, V., Kuneman, J. H., Geleijnse, M., Bax, J. J., Bertrand, P. B., Kodali, S. K., Mehran, R., Little, S. H., Houthuizen, P., & Van Mieghem, N. M. (2023). Dobutamine stress echocardiography remains indispensable for the diagnosis of low-flow low-gradient severe aortic stenosis. European Heart Journal, 44(Supplement_2). https://doi.org/10.1093/eurheartj/ehad655.1654

Allen, N. M., O’Rahelly, M., Eymard, B., Chouchane, M., Hahn, A., Kearns, G., Kim, D.-S., Byun, S. Y., Nguyen, C.-T. E., Schara-Schmidt, U., Kölbel, H., Marina, A. D., Schneider-Gold, C., Roefke, K., Thieme, A., Van den Bergh, P., Avalos, G., Álvarez-Velasco, R., Natera-de Benito, D., … Jungbluth, H. (2023). The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD). Brain, 146(10), 4233–4246. https://doi.org/10.1093/brain/awad153

Tavakoli, N. P., Gruber, D., Armstrong, N., Chung, W. K., Maloney, B., Park, S., Wynn, J., Koval‐Burt, C., Verdade, L., Tegay, D. H., Cohen, L. L., Shapiro, N., Kennedy, A., Noritz, G., Ciafaloni, E., Weinberger, B., Ellington, M., Schleien, C., … Spinazzola, R. (2023). Newborn screening for Duchenne muscular dystrophy: A two‐year pilot study. Annals of Clinical and Translational Neurology, 10(8), 1383–1396. Portico. https://doi.org/10.1002/acn3.51829

Wang, B. Z., Nash, T. R., Zhang, X., Rao, J., Abriola, L., Kim, Y., Zakharov, S., Kim, M., Luo, L. J., Morsink, M., Liu, B., Lock, R. I., Fleischer, S., Tamargo, M. A., Bohnen, M., Welch, C. L., Chung, W. K., Marx, S. O., Surovtseva, Y. V., … Fine, B. M. (2023). Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery. Cell Reports Medicine, 4(3), 100976. https://doi.org/10.1016/j.xcrm.2023.100976

Hussey, J. W., DeMarco, E., DiSilvestre, D., Jensen, H. H., Ben-Johny, M., Nyegaard, M., Overgaard, M. T., & Dick, I. E. (2023). Disease-associated calmodulin variants impair regulation of neuronal voltage-gated calcium channels. Biophysical Journal, 122(3), 105a. https://doi.org/10.1016/j.bpj.2022.11.754

Garcia Pavia, P., Gillmore, J. D., Kale, P., Berk, J. L., Maurer, M. S., Conceição, I., Dicarli, M., Solomon, S., Chen, C., Arum, S., Vest, J., Grogan, M., & Hababou, C. (2023). HELIOS-A: 18-month exploratory cardiac results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis. Archives of Cardiovascular Diseases Supplements, 15(1), 31–32. https://doi.org/10.1016/j.acvdsp.2022.10.056

Shimada, Y. J., Raita, Y., Liang, L. W., Maurer, M. S., Hasegawa, K., Fifer, M. A., & Reilly, M. P. (2022). Prediction of Major Adverse Cardiovascular Events in Patients With Hypertrophic Cardiomyopathy Using Proteomics Profiling. Circulation: Genomic and Precision Medicine, 15(6). https://doi.org/10.1161/circgen.121.003546

Yamabe, T., Ginns, J., Vedula, V., Leb, J. S., Shimada, Y. J., Weiner, S. D., & Takayama, H. (2022). REPLY FROM AUTHORS: Septal myectomy performed along the “septal band.” JTCVS Techniques, 16, 70–71. https://doi.org/10.1016/j.xjtc.2022.08.013

Lee, C., Liang, L. W., Hasegawa, K., Maurer, M. S., Tower-Rader, A., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2022). Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1724

Harano, N., Liang, L. W., Hasegawa, K., Maurer, M. S., Tower-Rader, A., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2022). Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using proteomics profiling. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1727

Lumish, H., Liang, L. W., Hasegawa, K., Maurer, M., Tower-Rader, A., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2022). Prediction of worsening heart failure in patients with hypertrophic cardiomyopathy using plasma proteomics profiling. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1723

Yamabe, T., Ginns, J., Vedula, V., Leb, J. S., Shimada, Y. J., Weiner, S. D., & Takayama, H. (2022). Left ventricular remodeling following septal myectomy in hypertrophic obstructive cardiomyopathy. JTCVS Open, 11, 105–115. https://doi.org/10.1016/j.xjon.2022.05.018

Lander, B. S., Zhao, Y., Hasegawa, K., Maurer, M. S., Tower-Rader, A., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2022). Comprehensive Proteomics Profiling Identifies Patients With Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in the Hypertrophic Cardiomyopathy Population. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.839409

Zhou, M., Ta, S., Hahn, R. T., Hsi, D. H., Leon, M. B., Hu, R., Zhang, J., Zuo, L., Li, J., Wang, J., Wang, B., Zhu, X., Liu, J., Han, Y., Li, X., Xu, B., Zhang, L., Hou, L., Han, C., … Liu, L. (2022). Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy. JAMA Cardiology, 7(5), 529. https://doi.org/10.1001/jamacardio.2022.0259

Lu, S., Hernan, R., Marcogliese, P. C., Huang, Y., Gertler, T. S., Akcaboy, M., Liu, S., Chung, H., Pan, X., Sun, X., Oguz, M. M., Oztoprak, U., de Baaij, J. H. F., Ivanisevic, J., McGinnis, E., Guillen Sacoto, M. J., Chung, W. K., & Bellen, H. J. (2022). Loss-of-function variants in TIAM1 are associated with developmental delay, intellectual disability, and seizures. The American Journal of Human Genetics, 109(4), 571–586. https://doi.org/10.1016/j.ajhg.2022.01.020

Gudigar, A., Raghavendra, U., Samanth, J., Dharmik, C., Gangavarapu, M. R., Nayak, K., Ciaccio, E. J., Tan, R.-S., Molinari, F., & Acharya, U. R. (2022). Novel Hypertrophic Cardiomyopathy Diagnosis Index Using Deep Features and Local Directional Pattern Techniques. Journal of Imaging, 8(4), 102. https://doi.org/10.3390/jimaging8040102

Glazer, A. M., Davogustto, G., Shaffer, C. M., Vanoye, C. G., Desai, R. R., Farber-Eger, E. H., Dikilitas, O., Shang, N., Pacheco, J. A., Yang, T., Muhammad, A., Mosley, J. D., Van Driest, S. L., Wells, Q. S., Shaffer, L. L., Kalash, O. R., Wada, Y., Bland, H. T., Yoneda, Z. T., … Roden, D. M. (2022). Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study. Circulation, 145(12), 877–891. https://doi.org/10.1161/circulationaha.121.055562

Ware, S. M., Bhatnagar, S., Dexheimer, P. J., Wilkinson, J. D., Sridhar, A., Fan, X., Shen, Y., Tariq, M., Schubert, J. A., Colan, S. D., Shi, L., Canter, C. E., Hsu, D. T., Bansal, N., Webber, S. A., Everitt, M. D., Kantor, P. F., Rossano, J. W., Pahl, E., … Lipshultz, S. E. (2022). The genetic architecture of pediatric cardiomyopathy. The American Journal of Human Genetics, 109(2), 282–298. https://doi.org/10.1016/j.ajhg.2021.12.006

Farooqi, N., Metherell, L. A., Schrauwen, I., Acharya, A., Khan, Q., Nouel Saied, L. M., Ali, Y., El-Serehy, H. A., Jalil, F., & Leal, S. M. (2021). Exome Sequencing Identifies a Novel FBN1 Variant in a Pakistani Family with Marfan Syndrome That Includes Left Ventricle Diastolic Dysfunction. Genes, 12(12), 1915. https://doi.org/10.3390/genes12121915

Akita, K., Kaneko, Y., Sato, R., Iguchi, K., Suwa, K., & Maekawa, Y. (2022). 4D Computed Tomography Visualization of Effective Septal Reduction After Alcohol Septal Ablation for Fatal Hypertrophic Obstructive Cardiomyopathy. Circulation Journal, 86(4), 725. https://doi.org/10.1253/circj.cj-21-0922

Shimada, Y. J., Raita, Y., Liang, L. W., Maurer, M. S., Hasegawa, K., Fifer, M. A., & Reilly, M. P. (2021). Comprehensive proteomics profiling reveals molecular pathways that are differentially regulated in hypertrophic cardiomyopathy and correlate with clinical markers of disease severity. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.1777

Argiro, A., Rosenblum, H., Griffin, J., Batra, J., Cappelli, F., Burkhoff, D., Maurer, M., & Olivotto, I. (2021). Sex related differences in exercise performance in patients with hypertrophic cardiomyopathy: hemodynamic insights through non-invasive pressure volume analysis. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.1558

Lander, B. S., Zhao, Y., Hasegawa, K., Maurer, M. S., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2021). Comprehensive proteomics profiling identifies patients with late gadolinium enhancement on cardiac magnetic resonance imaging in the hypertrophic cardiomyopathy population. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.1764

Shimada, Y. J., Raita, Y., Maurer, M. S., Hasegawa, K., Fifer, M. A., & Reilly, M. P. (2021). Prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy using proteomics profiling. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.1776

Liang, L. W., Raita, Y., Hasegawa, K., Fifer, M. A., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2021). Proteomics profiling reveals distinct molecular subtypes of hypertrophic cardiomyopathy with differential risks of major adverse cardiovascular events. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.1765

Morita, S. X., Zhao, Y., Hasegawa, K., Fifer, M. A., Maurer, M. S., Reilly, M. P., Takayama, H., & Shimada, Y. J. (2021). Effects of Septal Reduction Therapy on Acute Cardiovascular Events and All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy. International Heart Journal, 62(5), 1035–1041. https://doi.org/10.1536/ihj.21-095

Morita, S. X., Kusunose, K., Haga, A., Sata, M., Hasegawa, K., Raita, Y., Reilly, M. P., Fifer, M. A., Maurer, M. S., & Shimada, Y. J. (2021). Deep Learning Analysis of Echocardiographic Images to Predict Positive Genotype in Patients With Hypertrophic Cardiomyopathy. Frontiers in Cardiovascular Medicine, 8. https://doi.org/10.3389/fcvm.2021.669860

Ahimaz, P., Sabatello, M., Qian, M., Wang, A., Miller, E. M., Parrott, A., Lal, A. K., Chatfield, K. C., Rossano, J. W., Ware, S. M., Parent, J. J., Kantor, P., Yue, L., Wynn, J., Lee, T. M., Addonizio, L. J., Appelbaum, P. S., & Chung, W. K. (2021). Impact of Genetic Testing for Cardiomyopathy on Emotional Well-Being and Family Dynamics: A Study of Parents and Adolescents. Circulation: Genomic and Precision Medicine, 14(4). https://doi.org/10.1161/circgen.120.003189